Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma
Predicting dopamine agonist resistance in patients with macroprolactinoma is essential for clinicians to prevent treatment failure and subsequent complications such as medication-induced cerebrospinal fluid (CSF) rhinorrhea. We evaluated the features of patients with cabergoline resistance and CSF r...
Enregistré dans:
Auteurs principaux: | Hae-Kyung Kim, Jae-Won Hong, Ju-Hyung Moon, Sung-Soo Ahn, Eui-Hyun Kim, Seung-Koo Lee, Eun-Jig Lee, Yae-Won Park, Cheol-Ryong Ku |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e9510b45db974f3390a6d6e6d2b51516 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Reducing the risk of cerebrospinal fluid rhinorrhea following translabyrinthine surgery of the posterior fossa
par: Matthew W. Cooper, et autres
Publié: (2021) -
Macroprolactinoma en adolescentes: respuesta al tratamiento con bromocriptina
par: Reyes G,Maria Loreto, et autres
Publié: (1996) -
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
par: Rosa Pirchio, et autres
Publié: (2021) -
Resultados visuales en pacientes con macroprolactinoma tratados con agonistas de dopamina
par: Cuevas,José Luis, et autres
Publié: (2013) -
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
par: Yunzhi Zou, et autres
Publié: (2021)